Antigenically Intact Hemagglutinin in Circulating Avian and Swine Influenza Viruses and Potential for H3N2 Pandemic
Invention type: Technology
/
Case number: #16225
The present invention provides, among other things, technologies and methodologies for detection, treatment, and/or prevention of influenza transmission and/or infection. The present invention also provides technologies for monitoring influenza variants for their potential to present a pandemic risk to humans.
Researchers
Kannan Tharakaraman
/
Rahul Raman
/
Ram Sasisekharan
Departments: Department of Biological Engineering, School of Engineering
Technology Areas: Therapeutics: Proteins & Antibodies, Vaccines
Impact Areas: Healthy Living
-
human adaptation of h3 influenza
United States of America | Granted | 10,301,359
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.